| Matthew Blake Warren, MD | |
|
4234 Riverwalk Pkwy Ste 230, Riverside, CA 92505-3312 | |
| (951) 781-3672 | |
| Not Available |
| Full Name | Matthew Blake Warren |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 10 Years |
| Location | 4234 Riverwalk Pkwy Ste 230, Riverside, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124412275 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | A170797 (California) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | A170797 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkview Community Hospital Medical Center | Riverside, CA | Hospital |
| Riverside Community Hospital | Riverside, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| El-bershawi Medical Corp | 9032298492 | 39 |
News Archive
Dengue fever, transmitted by the Aedes mosquito, affects hundreds of millions of people in around one hundred tropical countries and causes 25 000 deaths per year. In the absence of a vaccine, determining the factors that influence epidemics to predict them better is a real public health challenge. One scientific study, conducted in New Caledonia, demonstrates the essential role of the local climate in epidemic dynamics. IRD researchers and their New Caledonian colleagues analysed epidemiological and climatological data gathered in Noumea over forty years.
Today, the U.S. Food and Drug Administration issued a warning letter to Mark Berman, M.D., of Beverly Hills, California, for illegally marketing an unapproved implantable device, the Pocket Protector, that Dr. Berman claims can prevent and treat a complication of breast implants known as capsular contracture, or tightening of scar tissue.
A research team from the University of Georgia's Regenerative Bioscience Center has found that a compound molecule used for drug delivery of insulin could be used to treat glioblastoma, an aggressive, usually fatal form of brain cancer.
In South Africa - "the quality of health care, including access to HIV prevention and testing services," largely depends on which of the country's 52 districts a resident lives in - according to findings in the latest District Health Barometer (DHB), an annual report by Health Systems Trust, IRIN reports. "Some of the inequities highlighted by the [report] can be traced to differences in health spending," IRIN writes.
In light of an aging population and increasing chronic vascular disease, there is a tremendous unmet need for new medical technologies to treat potentially dangerous chronic venous insufficiency (CVI) and blood clots, according to a Scientia Advisors review of the vascular device market released today. Both the CVI and the thrombosis segments present significant opportunities for medical device innovators.
› Verified 6 days ago
| Entity Name | El-bershawi Medical Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386813103 PECOS PAC ID: 9032298492 Enrollment ID: O20080509000414 |
News Archive
Dengue fever, transmitted by the Aedes mosquito, affects hundreds of millions of people in around one hundred tropical countries and causes 25 000 deaths per year. In the absence of a vaccine, determining the factors that influence epidemics to predict them better is a real public health challenge. One scientific study, conducted in New Caledonia, demonstrates the essential role of the local climate in epidemic dynamics. IRD researchers and their New Caledonian colleagues analysed epidemiological and climatological data gathered in Noumea over forty years.
Today, the U.S. Food and Drug Administration issued a warning letter to Mark Berman, M.D., of Beverly Hills, California, for illegally marketing an unapproved implantable device, the Pocket Protector, that Dr. Berman claims can prevent and treat a complication of breast implants known as capsular contracture, or tightening of scar tissue.
A research team from the University of Georgia's Regenerative Bioscience Center has found that a compound molecule used for drug delivery of insulin could be used to treat glioblastoma, an aggressive, usually fatal form of brain cancer.
In South Africa - "the quality of health care, including access to HIV prevention and testing services," largely depends on which of the country's 52 districts a resident lives in - according to findings in the latest District Health Barometer (DHB), an annual report by Health Systems Trust, IRIN reports. "Some of the inequities highlighted by the [report] can be traced to differences in health spending," IRIN writes.
In light of an aging population and increasing chronic vascular disease, there is a tremendous unmet need for new medical technologies to treat potentially dangerous chronic venous insufficiency (CVI) and blood clots, according to a Scientia Advisors review of the vascular device market released today. Both the CVI and the thrombosis segments present significant opportunities for medical device innovators.
› Verified 6 days ago
| Entity Name | Department Of State Hospitals |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124078704 PECOS PAC ID: 9638174238 Enrollment ID: O20081031000305 |
News Archive
Dengue fever, transmitted by the Aedes mosquito, affects hundreds of millions of people in around one hundred tropical countries and causes 25 000 deaths per year. In the absence of a vaccine, determining the factors that influence epidemics to predict them better is a real public health challenge. One scientific study, conducted in New Caledonia, demonstrates the essential role of the local climate in epidemic dynamics. IRD researchers and their New Caledonian colleagues analysed epidemiological and climatological data gathered in Noumea over forty years.
Today, the U.S. Food and Drug Administration issued a warning letter to Mark Berman, M.D., of Beverly Hills, California, for illegally marketing an unapproved implantable device, the Pocket Protector, that Dr. Berman claims can prevent and treat a complication of breast implants known as capsular contracture, or tightening of scar tissue.
A research team from the University of Georgia's Regenerative Bioscience Center has found that a compound molecule used for drug delivery of insulin could be used to treat glioblastoma, an aggressive, usually fatal form of brain cancer.
In South Africa - "the quality of health care, including access to HIV prevention and testing services," largely depends on which of the country's 52 districts a resident lives in - according to findings in the latest District Health Barometer (DHB), an annual report by Health Systems Trust, IRIN reports. "Some of the inequities highlighted by the [report] can be traced to differences in health spending," IRIN writes.
In light of an aging population and increasing chronic vascular disease, there is a tremendous unmet need for new medical technologies to treat potentially dangerous chronic venous insufficiency (CVI) and blood clots, according to a Scientia Advisors review of the vascular device market released today. Both the CVI and the thrombosis segments present significant opportunities for medical device innovators.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Blake Warren, MD Po Box 60219, Irvine, CA 92602-6007 Ph: (951) 781-3672 | Matthew Blake Warren, MD 4234 Riverwalk Pkwy Ste 230, Riverside, CA 92505-3312 Ph: (951) 781-3672 |
News Archive
Dengue fever, transmitted by the Aedes mosquito, affects hundreds of millions of people in around one hundred tropical countries and causes 25 000 deaths per year. In the absence of a vaccine, determining the factors that influence epidemics to predict them better is a real public health challenge. One scientific study, conducted in New Caledonia, demonstrates the essential role of the local climate in epidemic dynamics. IRD researchers and their New Caledonian colleagues analysed epidemiological and climatological data gathered in Noumea over forty years.
Today, the U.S. Food and Drug Administration issued a warning letter to Mark Berman, M.D., of Beverly Hills, California, for illegally marketing an unapproved implantable device, the Pocket Protector, that Dr. Berman claims can prevent and treat a complication of breast implants known as capsular contracture, or tightening of scar tissue.
A research team from the University of Georgia's Regenerative Bioscience Center has found that a compound molecule used for drug delivery of insulin could be used to treat glioblastoma, an aggressive, usually fatal form of brain cancer.
In South Africa - "the quality of health care, including access to HIV prevention and testing services," largely depends on which of the country's 52 districts a resident lives in - according to findings in the latest District Health Barometer (DHB), an annual report by Health Systems Trust, IRIN reports. "Some of the inequities highlighted by the [report] can be traced to differences in health spending," IRIN writes.
In light of an aging population and increasing chronic vascular disease, there is a tremendous unmet need for new medical technologies to treat potentially dangerous chronic venous insufficiency (CVI) and blood clots, according to a Scientia Advisors review of the vascular device market released today. Both the CVI and the thrombosis segments present significant opportunities for medical device innovators.
› Verified 6 days ago
Sang Kun Yim, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 7117 Brockton Ave, Riverside, CA 92506 Phone: 951-683-6370 | |
Sarah Chae, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4646 Brockton Ave Ste 201, Riverside, CA 92506 Phone: 951-585-1800 Fax: 951-585-1801 | |
Alina S Popa, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4445 Magnolia Ave, Riverside, CA 92501 Phone: 951-788-3636 | |
Richard M. Bradburne, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 909-353-2000 | |
Shelly C. Thio, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 909-353-2000 | |
Fawaz Gailani, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 909-353-2000 | |
Andrew Duke, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 4445 Magnolia Ave, Riverside, CA 92501 Phone: 951-788-3000 |